医学
免疫学
抗体
免疫球蛋白G
临床试验
内科学
作者
Kelly Gwathmey,Catherine M. Broome,Matthias Goebeler,Hiroyuki Murai,Zsuzsanna Bata‐Csörgõ,Adrian C. Newland,Jeffrey A. Allen,Yoshitaka Miyakawa,Peter Ulrichts,Luc Truyen,Jana Podhorna,René Kerstens,Sophie Steeland,Jon Beauchamp,Jeffrey T. Guptill,James F. Howard
标识
DOI:10.1080/1744666x.2025.2497840
摘要
Across clinical trials in IgG-mediated autoimmune diseases, efgartigimod was well tolerated with similar safety profiles regardless of dosing regimen.
科研通智能强力驱动
Strongly Powered by AbleSci AI